癌细胞的秘密室:微核,染色体和恶性瘤之间的联系
Truman Raleigh Mcneil1, Sweta Sikder1, Yamini Dalal1
1Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Open biology
|May 13, 2025
概括
含有缺陷蛋白质的微核会导致DNA碎片化,称为染色体. 这一过程通过激活瘤基因和禁用瘤抑制剂来促进癌症,使微核成为潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
- 癌症研究 癌症研究
背景情况:
- 微核具有缺陷的蛋白质组,使其染色质易受碎片化的影响.
- 这种称为染色体的DNA碎片化与癌症的发展有关.
- 微核被认为是瘤学中潜在的治疗点.
研究的目的:
- 审查最近关于微核形成的发现.
- 阐明微核在驱动色素三症中的作用.
- 探索染色体如何为癌细胞提供选择性优势.
主要方法:
- 关于最近科学发现的文献评论.
- 对微核生物生成研究的分析.
- 对染色体的机制和癌症生物学研究的审查.
主要成果:
- 微核的形成是前 chromothripsis 的一个关键事件.
- 染色体,由微核启动,导致瘤基因激活和瘤抑制器沉默.
- 染色体产生的基因组不稳定性为恶性细胞提供了生存优势.
结论:
- 微核是染色体的关键调解者,这是瘤发生的一个驱动因素.
- 准微核是癌症治疗的一个有希望的策略.
- 了解微核和染色体是促进癌症治疗的必要条件.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Separation of Sister Chromatids
3.5K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.5K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Attachment of Sister Chromatids
3.0K
As cells progress into mitosis, the nuclear envelope breaks down, and the condensed chromosomes are exposed to the array of bipolar microtubules of the mitotic spindle. The kinetochore, a large, disc-shaped protein complex, is present at the centromere region of the sister chromatids and acts as a binding site for the microtubules. Usually, the plus-end of a single microtubule is embedded within the kinetochore. However, some kinetochores first establish lateral contact with the side-wall...
3.0K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Mutagenicity and Carcinogenicity
1.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.1K


